Chang Jiang Ri Bao·2025-07-31 00:47Group 1 - Anpao Optoelectronics has established the world's first autonomous 8-inch thin-film lithium niobate wafer production line, positioning itself in the next-generation optical communication market [1] - The private enterprise Heyi Biotech has developed a recombinant human albumin injection (from rice), which has been approved for sale, becoming the world's first "rice-based" innovative drug [3][8] - The industrial investment in Wuhan is significantly driven by private enterprises, with nearly 70% of the total investment coming from them [4][5] Group 2 - Wuhan's high-tech manufacturing industry saw a 15.7% increase in value added in the first half of the year, with private enterprises contributing nearly half of the city's tax revenue [2] - The "little giant" enterprises and newly regulated companies in Wuhan have maintained double-digit growth in industrial output, significantly contributing to the development of emerging industries [9] - The total import and export volume of Wuhan's private enterprises reached 252.94 billion yuan in 2024, an 18.2% increase from 2023, accounting for 62.7% of the city's total import and export volume [11] Group 3 - Private enterprises in Wuhan are playing a crucial role in employment, contributing over 80% to the employment of new college graduates [12] - The private sector's R&D expenditure among the top 100 private enterprises in Wuhan increased by 21.36% compared to the previous year [5] - Companies like Sifang Optoelectronics are breaking international monopolies with their sensor integration modules, showcasing the global competitiveness of Wuhan's private enterprises [10]